INVARIANT LLC for CIGNA CORPORATION
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
Issues relating to P.L. 111-148, the Patient Protection and Affordable Care Act, and P.L. 111-152, the Health Care and Education Reconciliation Act of 2010; monitor H.R. 748 / S. 684, the Middle Class Health Benefits Tax Repeal Act of 2019, and H.R. 1398 / S. 172, the Health Insurance Tax Relief Act of 2019.
| Lobbyist | Covered position, as disclosed |
|---|---|
| BENJAMIN KLEIN | — |
| KATHRYN WISE | — |
Medicare/Medicaid MMM
Monitor issues related to the drug pricing RFI, the Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs; proposals that impact Medicare Part D such as formulary requirements, pharmacy benefit manager (PBM) disclosure provisions, closing the Part D coverage gap, and direct negotiation of prescription drug prices.
| Lobbyist | Covered position, as disclosed |
|---|---|
| BENJAMIN KLEIN | — |
| KATHRYN WISE | — |
Health Issues HCR
Issues relating to P.L. 111-148, the Patient Protection and Affordable Care Act, and P.L. 111-152, the Health Care and Education Reconciliation Act of 2010, including exchanges, cost sharing reduction, market reforms, coverage expansion proposals, and non-discrimination provisions; monitor proposals to end surprise billing.
| Lobbyist | Covered position, as disclosed |
|---|---|
| BENJAMIN KLEIN | — |
| KATHRYN WISE | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.